Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Eur J Pharm Biopharm. 2016 Aug 12;108:126–135. doi: 10.1016/j.ejpb.2016.08.005

Table 2. Development of HDL-mimicking α-tocopherol-coated NPs. Listed are the compositions per 1 ml NPs.

(A) The array #1 with high contents of CO without TPGS, (B) modified 2 A by adding TPGS into the compositions, (C) The array #2 with low contents of CO without TPGS, and (D) modified 2C by adding TPGS into the composition.

A.
Experiment PC (µg) SM (µg) PS (µg) CO (µg) Particle size (nm) P.I.
1–1 32 6 4 40 275.4 0.265
1–2 32 6 4 50 383.4 0.181
1–3 32 6 4 60 242.9 0.295
1–4 40 7.5 5 40 284.1 0.31
1–5 40 7.5 5 50 333.6 0.301
1–6 40 7.5 5 60 404.1 0.193
1–7 48 9 6 40 386.4 0.284
1–8 48 9 6 50 282.6 0.297
1–9 48 9 6 60 255.2 0.255
B.
Experiment PC (µg) SM (µg) PS (µg) CO (µg) TPGS (µg) Particle size (nm) P.I.
2–1 32 6 4 40 60 173 0.261
2–2 32 6 4 50 40 181.9 0.236
2–3 32 6 4 60 20 198.7 0.223
2–4 40 7.5 5 40 30 173.1 0.263
2–5 40 7.5 5 50 40 190 0.239
2–6 40 7.5 5 60 20 166 0.27
2–7 48 9 6 40 30 173.1 0.271
2–8 48 9 6 50 10 202 0.28
2–9 48 9 6 60 20 211.4 0.294
C.
Experiment PC (µg) SM (µg) PS (µg) CO (µg) Particle size (nm) P.I.
3–1 40 7.5 2.5 5 246.6 0.312
3–2 40 7.5 2.5 10 301.7 0.307
3–3 56 10.5 3.5 5 269.2 0.234
3–4 56 10.5 3.5 10 296.1 0.332
D.
Experiment PC (µg) SM (µg) PS (µg) CO (µg) TPGS (µg) Particle size (nm) P.I.
4–1 40 7.5 2.5 5 30 192.7 0.259
4–2 40 7.5 2.5 10 30 178.9 0.283
4–3 56 10.5 3.5 5 50 171.6 0.295
4–4 56 10.5 3.5 10 50 162 0.268